Call Options Transactions Made in Q3 2024 in Akero Therapeutics, Inc. (AKRO)
This table provides information about the institutional ownership of Akero Therapeutics, Inc. (AKRO) during Q3 2024. The information is specifically focused on institutions that hold call options of Akero Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
CALL |
31.5KNew |
$676K - $924K
|
31.5K
$965K
|
|
|
Nov 14, 2024
Q3 2024
|
Adar1 Capital Management, LLC
Austin, TX |
BUY
|
CALL |
22.5KNew |
$483K - $660K
|
22.5K
$689K
|
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
BUY
|
CALL |
10.1KNew |
$217K - $296K
|
10.1K
$309K
|
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
9.7K+ 8.45% |
$208K - $285K
|
125K
$3.81M
|
|
|
Nov 14, 2024
Q3 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
BUY
|
CALL |
9KNew |
$193K - $264K
|
9K
$276K
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-16.6K- 28.72% |
$356K - $487K
|
41.2K
$1.26M
|